TORONTO, May 2, 2018 /CNW/ - The British Columbia (B.C.) Court of Appeal has dismissed a proposed class action proceeding related to the effectiveness of COLD-FX. Valeant Canada, manufacturer of COLD-FX, is pleased to see this matter closed.
At Valeant Canada, we are dedicated to improving people's lives with our healthcare products. COLD-FX has been thoroughly evaluated, researched and clinically assessed and has been proven to help reduce the frequency, severity and duration of cold and flu symptoms by boosting the immune system.[i] More than $20 million has been invested over more than a decade in clinical research and development of COLD-FX. For eleven years, COLD-FX has been the #1 Pharmacist and Doctor Recommended Natural Cold Remedy brand in Canada.[ii]
About Valeant Canada and COLD-FX
COLD-FX is produced by Valeant Canada, a subsidiary of Valeant Pharmaceuticals International, Inc., a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology and branded generics. More information about COLD-FX can be found at www.cold-fx.ca. More information about Valeant Canada can be found at www.valeantcanada.com.
| ___________________________________ |
| [i] Health Canada "COLD-FX Monograph": https://health-products.canada.ca/lnhpd-bdpsnh/info.do?licence=80002849. Accessed April 27, 2018 |
| [ii] Canadian Healthcare Network. "2016 Counselling and Recommendations Survey." Retrieved from: http://www.canadianhealthcarenetwork.ca/otc2016/pharmacists-physicians Accessed April 27, 2018 |
SOURCE COLD-FX
Rob McEwan, Argyle Public Relationships, 416-968-7311 ext. 242, [email protected]
Share this article